Skip to main content
SpringerLink
Log in

Menstrual and Hormonal Dysfunction

  • Chapter
  • First Online:
Nursing Management of Women’s Health

  • 694 Accesses

Abstract

This chapter covers the most common conditions that women experience and report those that can often lead to a referral to a gynaecology department. It is common for these conditions to be investigated and managed by nurse specialists. The chapter encompasses heavy menstrual bleeding, fibroids, intermenstrual bleeding (IMB), post-coital bleeding (PCB; or non-abnormal screening reasons), post-menopausal bleeding (PMB), polycystic ovarian syndrome (PCOS) and pre-menstrual syndrome (PMS).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. BMJ Best Practice (2018) Assessment of menorrhagia. BMJ Publishing

    Google Scholar 

  2. NICE Clinical Guideline (2018) Heavy menstrual bleeding. Lumsden MA, Rees M (2014) Menstrual problems, 2nd edn. RCOG, London. https://www.nice.org.uk/guidance/ng88

  3. Alexandra I et al (2016) Women’s health care in advanced practice nursing. Chapter 28: Peri menstrual and pelvic symptoms and syndromes. Springer, New York

    Book  Google Scholar 

  4. AAGL practice report (2012) Practice guidelines for the diagnosis and management of endometrial polyps. J Minim Invasive Gynecol 19(1):3–9

    Article  Google Scholar 

  5. https://www.rcog.org.uk/globalassets/documents/guidelines/green-top-guidelines/gtg_67_endometrial_hyperplasia.pdf. 2016

  6. Royal College of Obstetricians and Gynaecologists/BSGE (2011) Best practice in outpatient hysteroscopy (Green Top Guideline No. 59). https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg59/. Accessed 7 Jul 2018

  7. Bryant Smith A, Lethaby A, Farquhar C, Hikey M (2018) Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev 4: CD000249

    Google Scholar 

  8. Buttram VC, Reiter RC (1981) Uterine leiomyomata: etiology, symptomatology and management. Fertil Steril 36:433–445

    Article  Google Scholar 

  9. Holloway D (2017). https://www.guidelinesfornurses.co.uk/womens-health/practical-tips-for-the-diagnosis-and-management-of-fibroids/453725.article

  10. BMJ Best Practice (2018) Fibroids. BMJ, London

    Google Scholar 

  11. Lumsden MA, West CP, Thomas E, Coutts J, Hillier H, Thomas N, Baird DT (1994) Treatment with the gonadotrophin releasing hormone-agonist goserelin before hysterectomy for uterine fibroids. BJOG 101:438–442

    Article  CAS  Google Scholar 

  12. Chabbert-Buffet N, Kolanska K et al (2018) Selective progesterone receptor modulators: current applications and perspectives. Climacteric 21(4):375–379. https://doi.org/10.1080/13697137.2017.1386650

    Article  CAS  PubMed  Google Scholar 

  13. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/esmya-ulipristal-acetate%2D%2D-mhra-safety-alert/

  14. Lumsden MA (2010) Modern management of fibroids. Obstet Gynaecol Reprod Med 20(3):82–86

    Article  Google Scholar 

  15. BMJ Best Practice (2018) Assessment of vaginal bleeding. BMJ

    Google Scholar 

  16. Sweet MG, Schmidt-Dalton TA, Weiss PM et al (2012) Evaluation and management of abnormal uterine bleeding in premenopausal women. Am Fam Physician 185(1):35–43

    Google Scholar 

  17. Management of Unscheduled Bleeding in Women Using Hormonal Contraception; Faculty of Sexual and Reproductive Healthcare (2009). https://www.rcog.org.uk/globalassets/documents/guidelines/unscheduledbleeding23092009.pdf

  18. Guruwadayarhalli B, Jones SE, Srinivasan V (2007) Hysteroscopy in the diagnosis of postmenopausal bleeding. Menopause Int 13(3):132–134

    Article  Google Scholar 

  19. Scottish Intercollegiate Guidelines Network (2002) Investigation of post-menopausal bleeding: a national clinical guideline. SIGN publication no 61. SIGN, Edinburgh

    Google Scholar 

  20. Bray F, Dos S, Silva I, Moller H, Weiderpass E (2005) Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomark Prev 14(5):1132–1142

    Article  Google Scholar 

  21. National Institute of Clinical Excellence (2017) https://www.nice.org.uk/guidance/ng12

  22. Mackintosh M, Crosbie E (2012) Obesity driven endometrial cancer: is weight loss the answer? BJOG 120:791–794

    Article  Google Scholar 

  23. Kalampokas T, Sofoudis C, Anastasopoulos C et al (2013) Effects of tamoxifen on postmenopausal endometrium. Eur J Gynaecol Oncol 34(4):325–328

    CAS  PubMed  Google Scholar 

  24. Manchanda R, Menon U, Michaelson-Cohen R, Beller U, Jacobs I (2009) Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective. Curr Opin Obstet Gynecol 21(1):31–38

    Article  Google Scholar 

  25. Humphrey MM, Apte SM (2009) The use of minimally invasive surgery for endometrial cancer. Cancer Control 16(1):30–37

    Article  Google Scholar 

  26. https://www.figo.org/sites/default/files/uploads/IJGO/papers/AUB%20Classification.pdf

  27. BMJ Best Practice (2018) Polycystic ovary syndrome. BMJ

    Google Scholar 

  28. Connolly A (2018) Polycystic ovary syndrome requires long term holistic care. Guidelines in practice

    Google Scholar 

  29. RCOG Green Top Guidelines (2014) Long term consequences of polycystic ovary syndrome. RCOG Green Top Guideline number 33

    Google Scholar 

  30. ESHRE. https://www.monash.edu/medicine/sphpm/mchri/pcos/guideline

  31. Brooke T, Mimouni NEH, Barbotin A et al (2018) Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med 24:834–846

    Article  Google Scholar 

  32. https://www.fsrh.org/ukmec/

  33. https://www.nice.org.uk/advice/esuom6/chapter/key-points-from-the-evidence

  34. Morris EJ (2001) The role of infertility nurses in ovulation induction programmes. Hum Fertil 4(1):14–17

    Article  CAS  Google Scholar 

  35. Kumarendran B, O’Reilly M, Manolopoulos K et al (2018) Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database. PLoS 15(3):e1002542

    Article  Google Scholar 

  36. BMJ Best Practice (2017) Premenstrual syndrome and dysphoric disorder. BMJ

    Google Scholar 

  37. Panay N. NAPS guidelines on premenstrual syndrome. https://www.pms.org.uk/assets/files/guidelinesfinal60210.pdf

  38. Green LJ, O’Brien P, Panay N, Craig M, on behalf of RCOG (2017) Management of premenstrual syndrome. RCOG Green Top Guideline 48

    Google Scholar 

  39. Dehnvi M, Jafarnejad F, Sadeghu Goghary S (2018) The effect of 8 weeks of aerobic exercise on the severity of physical symptoms of premenstrual syndrome: a clinical trial study. BMC Womens Health 18(1):80

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Guys and St Thomas NHS Foundation Trust, London, UK

    Anne Teasdale & Debra Holloway

  2. North Bristol NHs Trust, Bristol, UK

    Katharine Gale

Authors
  1. Anne Teasdale
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katharine Gale
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Debra Holloway
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Debra Holloway .

Editor information

Editors and Affiliations

  1. Guy’s Hospital, Guy’s and St Thomas NHS Foundation Trust, London, UK

    Debra Holloway

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Teasdale, A., Gale, K., Holloway, D. (2019). Menstrual and Hormonal Dysfunction. In: Holloway, D. (eds) Nursing Management of Women’s Health. Springer, Cham. https://doi.org/10.1007/978-3-030-16115-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-16115-6_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-16114-9

  • Online ISBN: 978-3-030-16115-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation